| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.098 | 0.09 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |